# ‘No evidence’ cannabis works for most mental health disorders: Review – RACGP > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-mental-health-conditions-evidence-review/ > **Published:** 2026-03-17T09:26:12-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:58:19-04:00 > **Clinical Summary:** Review shows cannabis mental health conditions treatment lacks strong evidence, highlighting risks and clinical guidance needs. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. Mental HealthResearchTHCSafetyPolicy Why This Matters Clinicians need this evidence summary to counsel patients seeking cannabis for mental health conditions, as the review demonstrates insufficient research supporting efficacy for most psychiatric disorders despite widespread off-label use. This gap between patient demand and clinical evidence creates liability and safety risks, requiring practitioners to establish clear prescribing guidelines and educate patients about unproven benefits. For Australian clinicians specifically, this finding should inform therapeutic decision-making given the regulatory environment permitting access to cannabis products. Clinical Summary A recent evidence review by the Royal Australian College of General Practitioners found insufficient scientific support for [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in treating most [mental health disorders](https://cedclinic.com/cannabinoid-receptor-type-2-schizophrenia/), despite THC products being prescribed second only to pain conditions in Australia. The review highlights a concerning disconnect between clinical prescribing patterns and available evidence, as mental health indications now represent a substantial proportion of cannabis authorizations without robust randomized controlled trials demonstrating efficacy. Current evidence suggests potential benefits may be limited to specific conditions like chemotherapy-induced nausea, with most psychiatric applications lacking adequate research foundation. This gap between practice and evidence is particularly problematic given that many patients seeking cannabis for anxiety, depression, and other mental health conditions may be exposed to THC’s known risks, including psychosis, [cognitive impairment](https://cedclinic.com/acute-effects-partial-cb1-receptor-agonists-cognition/), and [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/), without demonstrated therapeutic benefit. Clinicians should exercise caution when considering cannabis for mental health indications and counsel patients that evidence-based alternatives remain the standard of care for these conditions. For practitioners considering cannabis prescriptions, prioritizing indications with established evidence and discussing with patients the lack of research support for psychiatric applications represents a more defensible and safer clinical approach. Dr. Caplan’s Take “What we’re seeing in my practice is patients coming in with cannabis already in hand for anxiety or depression, having self-diagnosed based on anecdotal reports, when the evidence simply doesn’t support efficacy for these conditions and can actually worsen psychiatric symptoms in vulnerable individuals. We need to have honest conversations about this gap between patient expectations and clinical evidence rather than defaulting to either cheerleading or dismissal.” Clinical Perspective While cannabis use for mental health conditions has grown substantially in clinical practice, recent evidence reviews highlight a critical gap between patient demand and robust scientific support for most psychiatric indications. The Royal Australian College of General Practitioners’ assessment reflects a broader international consensus that evidence for efficacy in depression, anxiety, and other common mental health disorders remains limited or absent, with particular concern around THC-dominant products that may actually worsen certain conditions. Clinicians should be aware that patient expectations often exceed available evidence, partly driven by anecdotal reports and evolving legal status, yet prescribing without solid evidence risks harm from adverse effects, dependency, and delayed appropriate treatment. Important confounders include heterogeneous product composition, variable dosing practices, self-selection bias in observational studies, and difficulty separating symptom relief from placebo effects or self-medication patterns. In practice, clinicians should document the evidence limitation clearly in conversations with patients seeking cannabis for mental 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/mental-health/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+%27No+evidence%27+cannabis+works+for+most+mental+health+disorders%3A+Review+-+RACGP+%40drcaplan&url=https%3A%2F%2Fwww1.racgp.org.au%2Fnewsgp%2Fclinical%2Fno-evidence-cannabis-works-for-most-mental-health)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww1.racgp.org.au%2Fnewsgp%2Fclinical%2Fno-evidence-cannabis-works-for-most-mental-health)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+%27No+evidence%27+cannabis+works+for+most+mental+health+disorders%3A+Review+-+RACGP+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww1.racgp.org.au%2Fnewsgp%2Fclinical%2Fno-evidence-cannabis-works-for-most-mental-health)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [Medical cannabis isn’t an effective treatment for anxiety, depression or PTSD, new research shows](https://cedclinic.com/medical-cannabis-mental-health-research-evidence/) - [AM News Update: March 17, 2026](https://cedclinic.com/cannabis-clinical-trials-mental-health-march-2026/) - [Louisville dispensary helps patients apply for medical cannabis cards at reduced cost | Wdrb-video](https://cedclinic.com/medical-cannabis-card-access-barriers-louisville-dispensary/) 📰 Source: [https://www1.racgp.org.au/newsgp/clinical/no-evidence-cannabis-works-for-most-mental-health](https://www1.racgp.org.au/newsgp/clinical/no-evidence-cannabis-works-for-most-mental-health) Further Reading CED Clinic Blog[Cannabis-Infused Beverages as Alcohol Alternatives: New York at Five Years](https://cedclinic.com/cannabis-beverage-substitution-alcohol-new-york-five-years/) Research Digest[AM Policy Update: March 17, 2026](https://cedclinic.com/dea-synthetic-opioids-schedule-i-march-17-2026/) Evidence Watch[Cannabinoid Clinical Trials: CBD Cortical Excitability Study](https://cedclinic.com/cannabidiol-lacks-intrinsic-anti-epileptic-properties-trial/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Study Finds Little Proof Cannabis Helps Most Mental Health Conditions](https://cedclinic.com/cannabis-effectiveness-mental-health-study-limited-evidence/) This article reviews recent research showing limited evidence supporting cannabis use for mental health conditions. [Read More](https://cedclinic.com/cannabis-effectiveness-mental-health-study-limited-evidence/) [Does Medicinal Cannabis Work for Depression, Anxiety or PTSD? Our Study Says There's No Evidence](https://cedclinic.com/medicinal-cannabis-depression-anxiety-ptsd-evidence-review/) Explore findings from a study that found no evidence supporting medicinal cannabis for common psychiatric disorders. [Explore Study](https://cedclinic.com/medicinal-cannabis-depression-anxiety-ptsd-evidence-review/) [Medical Cannabis Isn't an Effective Treatment for Anxiety, Depression or PTSD, New Research Shows](https://cedclinic.com/medical-cannabis-mental-health-research-evidence/) New research highlights the ineffectiveness of [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) for treating anxiety, depression, and PTSD. [Learn More](https://cedclinic.com/medical-cannabis-mental-health-research-evidence/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).